Drugmakers turn up marketing efforts in diabetes market
With a half-dozen new products lined up for approval within two years, the fight to win the growing $22 billion U.S. diabetes market is expected to intensify.
With a half-dozen new products lined up for approval within two years, the fight to win the growing $22 billion U.S. diabetes market is expected to intensify.
Honda and Subaru led U.S. sales gains in August as auto demand beat projections and Asia-based carmakers, buoyed by Toyota Motor Corp., combined for their best month ever.
Residents in Princeton, N.J., have sued the municipality and Princeton University, saying the school should lose its tax-exempt status because it shares drug royalties with faculty. The case could have major repercussions for research universities.
College sports’ governing body probably will consider new rules in the coming months that allow the most powerful football programs to spend more on their athletes, while giving poorer programs the option to adopt them.
Drugmakers under investigation for bribery have stopped promoting products in China, and physicians in some hospitals no longer want to meet sales representatives. Eli Lilly is among the drugmakers in China facing allegations.
Subaru, which employs about 3,600 people in Lafayette, is taking measured steps to expand its production capacity, but today it is worried about running out of cars.
College sports’ governing body grew its investment portfolio to $527 million for the year ended June 30, with an 11-percent gain in its $304.5 million quasi-endowment and an 8.8-percent return in its $222.5 million operating reserve.
Indiana University’s Kelley School of Business is expanding its certificate programs for executives, combining noncredit webinars, for-credit certificates, and graduate degrees into a single educational program, mostly for corporate clients.
Eli Lilly and Co. said it is investigating allegations its employees paid Chinese doctors at least $4.9 million in bribes and kickbacks to promote the sales of two diabetes drugs.
Cummins said the 5-liter, V-8 turbo diesel will be built in Indiana at the company's historic plant in downtown Columbus, creating up to 500 jobs over the next several years. About 300 people currently work on the V-8 program.
If approved, the drug would be a potent boost to Lilly’s product portfolio. It would also mean a critical new therapy for a cancer that’s proven difficult to treat.
Executives at the company, which counts Toyota Motor Corp. as its biggest shareholder, will begin discussions this month through next year to determine the long-term direction of the Tokyo-based company.
Indiana-based Zimmer Holdings Inc., which lost a February trial against Stryker Corp. over a surgical device patent, was told to pay three times the jury award, plus other costs.
OC Oerlikon Corp. interim CEO Juerg Fedier said margins are improving in the Fairfield Drive Systems division in Lafayette after the Swiss manufacturer cut nearly 500 jobs in the second quarter.
Frontier Airlines, the Denver-based airline owned by Indianapolis-based Republic Airways Holdings, may soon become a legitimate down-market competitor.
Spirit Airlines Inc.’s largest investor, private-equity firm Indigo Partners LLC, is preparing to sell its stake in the discount carrier in what could be preparation to make a bid for Frontier Airlines, a Cowen & Co. analyst said Wednesday.
Simon Property Group Inc. reported an increase in second-quarter funds from operations, revenue, occupancy and base rents.
Coal use in the United States will continue to fall, though the slide will be gradual as electric utilities switch to cleaner alternatives over “years and years,” billionaire Warren Buffett said at an event in Carmel this week.
WellPoint Inc., the second-biggest U.S. health insurer, said more small employers are scaling back benefits this year, a potential hedge against higher costs expected under the U.S. health-care law.
Strong sales and penny-pinching helped Eli Lilly and Co. beat Wall Street’s expectations in the second quarter, leading the company to raise its profit forecast for the year.